Distortion-Product Otoacoustic Emissions: A Useful Test for Monitoring Ototoxicity Induced by Pegylated Interferon and Ribavirin Treatment in Patients with Chronic Hepatitis C-Reference-Cited by-同舟云学术

Distortion-Product Otoacoustic Emissions: A Useful Test for Monitoring Ototoxicity Induced by Pegylated Interferon and Ribavirin Treatment in Patients with Chronic Hepatitis C

Published:2012-04 Issue:2 Volume:25 Page:551-556
ISSN:0394-6320
Container-title:International Journal of Immunopathology and Pharmacology
language:en
Short-container-title:Int J Immunopathol Pharmacol

Author:

Casale M.¹,Mazzarelli C.²,Gentilucci U. Vespasiani²,Potena M.¹,Pappacena M.¹,Faiella F.¹,Galati G.²,Salvinelli F.¹,Picardi A.²

Affiliation:

1. Department of Otolaryngology, Interdisciplinary Center for Biomedical Research (CIR), University Campus Bio-Medico, Rome, Italy

2. Department of Clinical Medicine and Hepatology Unit, Interdisciplinary Center for Biomedical Research (CIR), University Campus Bio-Medico, Rome, Italy

Publisher

SAGE Publications

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://journals.sagepub.com/doi/pdf/10.1177/039463201202500229

Reference22 articles.

1. Effect of interferon treatment on hearing of patients with chronic Hepatitis C

2. Chronic Hepatitis C Infection

3. Sudden Hearing Loss in Patients with Chronic Hepatitis C Treated with Pegylated Interferon/Ribavirin

4. Acute sensorineural hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment: Outcome after resumption of therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avaliação audiológica em pacientes com hepatite C crônica tratados por antivirais de ação direta;Audiology - Communication Research;2022